The Effects of Naltrexone on Subjective Response to Methamphetamine in a Clinical Sample: a Double-Blind, Placebo-Controlled Laboratory Study

@article{Ray2015TheEO,
  title={The Effects of Naltrexone on Subjective Response to Methamphetamine in a Clinical Sample: a Double-Blind, Placebo-Controlled Laboratory Study},
  author={Lara A Ray and Spencer Bujarski and Kelly E. Courtney and Nathasha R. Moallem and Katy F Lunny and Daniel James Olan Roche and Adam M. Leventhal and Steven Shoptaw and Keith Gregory Heinzerling and Edythe D. London and Karen Dal Lago Miotto},
  journal={Neuropsychopharmacology},
  year={2015},
  volume={40},
  pages={2347-2356}
}
Methamphetamine (MA) use disorder is a serious psychiatric condition for which there are no FDA-approved medications. Naltrexone (NTX) is an opioid receptor antagonist with demonstrated efficacy, albeit moderate, for the treatment of alcoholism and opioid dependence. Preclinical and clinical studies suggest that NTX may be useful for the treatment of MA use… CONTINUE READING